NCT06411912CompletedPhase 2
A Study of NIDO-361 in Patients With SBMA
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of NIDO-361 in Patients With Spinal and Bulbar Muscular Atrophy (SBMA)
Source: ClinicalTrials.gov · Last updated 3 Mar 2026
Brief summary (registry, in English)
The purpose of this study is to evaluate the safety, tolerability, and efficacy of NIDO-361 in adult patients with Spinal and Bulbar Muscular Atrophy (SBMA).
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 54 (actual)
- First submitted
- 8 May 2024
- Start date
- 1 Mar 2024
- Primary completion date
- 22 Oct 2025
- Lead sponsor
- Nido Biosciences, Inc.
- NCT number
- NCT06411912
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 54
- From 1 Mar 2024 to the primary completion date, 22 Oct 2025
- 5 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinically significant cardiovascular, endocrine, hepatic, renal, pulmonary, gastrointestinal, neurologic, immunologic, malignant, metabolic, psychiatric, or other condition that, in the opinion of the Investigator, precludes the participant's safe participation in the study or would interfere with the study assessments
Other
- Inability to undergo MRI (mild sedation may be allowed)
Who the study is looking for
- Ambulatory male
- Documented SBMA diagnosis confirmed by DNA genetic testing
- Able to complete six-minute walk test (6MWT)
Age in the registry: 18 years to 70 years · Sex: Male · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rigshospitalet, Klinik for Nerve- og Muskelsygdomme & Copenhagen Neuromuscular Center Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
| University of College London Hospital (UCLH) Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| IRCCS Istituto Neurologico Carlo Besta Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
| Azienda Ospedale Università di Padova Coordinator of this site? Confirm its status | Padova | Italy | Unknown status |
| Kyungpook National University Chilgok Hospital Coordinator of this site? Confirm its status | Daegu | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.